These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8723174

  • 1. Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
    Berti S, Palmieri C, Ravani M, Bonini R, Iascone MR, Clerico A, Manfredi C, Iervasi G, Ferrazzi P, Biagini A.
    Cardiovasc Drugs Ther; 1996 Mar; 10(1):81-7. PubMed ID: 8723174
    [Abstract] [Full Text] [Related]

  • 2. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A, Stanek B, Kubecova L, Vitovec J, Spinar J, Yilmaz N, Kos T, Hartter E, Frey B, Pacher R.
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [Abstract] [Full Text] [Related]

  • 3. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
    Neuzner J, Mitrovic V, Pitschner HF, Lissmann H, Schlepper M.
    Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628
    [Abstract] [Full Text] [Related]

  • 4. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW, Heinzler R, Wirtz JH, Fieten-Rumswinkel M, Braun P, May E, Hetzer R, Heinrich KW.
    Z Kardiol; 1994 Jun; 83 Suppl 2():49-53. PubMed ID: 8091824
    [Abstract] [Full Text] [Related]

  • 5. High-dose enoximone to evaluate reversibility of pulmonary hypertension: is there a diagnostic value of neurohormonal measurements?
    Schulz O, Mitrovic V, Schönburg M, Thormann J.
    Am Heart J; 1999 May; 137(5):887-94. PubMed ID: 10220638
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of prolonged enoximone infusion (7 days) in patients with severe chronic heart failure.
    Gibelin P, Dadoun-Dybal M, Candito M, Robillon JF, Morand P.
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):333-6. PubMed ID: 8364003
    [Abstract] [Full Text] [Related]

  • 7. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure.
    Ungar A, Fumagalli S, Marini M, Di Serio C, Tarantini F, Boncinelli L, Baldereschi G, Valoti P, La Cava G, Olianti C, Masotti G, Marchionni N.
    Crit Care Med; 2004 May; 32(5):1125-9. PubMed ID: 15190961
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamics of enoximone during intravenous infusion.
    Winkle RA, Smith NA, Ruder MA, Mead RH, Lebsack C, Bekele T, Kates RE, Rubin J, Okerholm R.
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S1-2. PubMed ID: 2145232
    [Abstract] [Full Text] [Related]

  • 9. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

  • 10. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
    Galie N, Branzi A, Magnani G, Melandri G, Caldarera I, Rapezzi C, Grattoni C, Magnani B.
    Cardiovasc Drugs Ther; 1993 Jun 02; 7(3):337-47. PubMed ID: 8364004
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure.
    Smith NA, Kates RE, Lebsack C, Ruder MA, Mead RH, Bekele T, Okerholm RA, Rubin GM, Winkle RA.
    Am Heart J; 1991 Sep 02; 122(3 Pt 1):755-63. PubMed ID: 1831585
    [Abstract] [Full Text] [Related]

  • 12. Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure.
    Shekhar YC, Anand IS, Sarma R, Ferrari R, Wahi PL, Poole-Wilson PA.
    Am J Cardiol; 1991 Apr 01; 67(8):732-6. PubMed ID: 2006623
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
    Brenard R, Moreau R, Pussard E, Champigneulle B, Gaudin C, Hadengue A, Braillon A, Lebrec D.
    J Hepatol; 1992 Mar 01; 14(2-3):347-56. PubMed ID: 1386858
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
    Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJ.
    J Clin Invest; 1986 Nov 01; 78(5):1362-74. PubMed ID: 2945832
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.
    Hepatology; 1998 Oct 01; 28(4):937-43. PubMed ID: 9755229
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure.
    Münzel T, Drexler H, Holtz J, Kurtz S, Just H.
    Circulation; 1991 Jan 01; 83(1):191-201. PubMed ID: 1845857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.